Discontinuing Cancer Screening for Older Adults: a Comparison of Clinician Decision-Making for Breast, Colorectal, and Prostate Cancer Screenings

Author(s):  
Justine P. Enns ◽  
Craig E. Pollack ◽  
Cynthia M. Boyd ◽  
Jacqueline Massare ◽  
Nancy L. Schoenborn
2014 ◽  
Vol 25 (3) ◽  
pp. 1262-1277 ◽  
Author(s):  
Dawood H. Sultan ◽  
Brian M. Rivers ◽  
Ben O. Osongo ◽  
Danyell S. Wilson ◽  
April Schenck ◽  
...  

2018 ◽  
Vol 12 (4) ◽  
pp. 884-893 ◽  
Author(s):  
Jennifer D. Allen ◽  
Ifedayo C. Akinyemi ◽  
Amanda Reich ◽  
Sasha Fleary ◽  
Shalini Tendulkar ◽  
...  

Routine prostate cancer screening is not recommended but African American men who are at higher risk for the disease should be offered the opportunity for shared decision-making with their health-care providers. This qualitative study sought to better understand the potential role of women in educating their male spouses/partners about prostate cancer screening. Nine focus groups were conducted ( n = 52). Women were recruited from a variety of community venues. Those eligible were African American and married to or in a partnership with an African American male age ≥ 45. Women provide numerous types of support to their male partners in an effort to facilitate participation in preventive health care. While women agreed that they would like to educate their partners about prostate cancer screening, they had little information about screening guidelines or the potential harms and limitations. The current findings suggest that women are eager information-seekers and can disseminate information to men and facilitate their efforts to make more informed decisions about prostate cancer screening. Women should be included in educational interventions for to promote informed decision-making for prostate cancer screening.


2010 ◽  
Vol 30 (5_suppl) ◽  
pp. 53-64 ◽  
Author(s):  
Richard M. Hoffman ◽  
Carmen L. Lewis ◽  
Michael P. Pignone ◽  
Mick P. Couper ◽  
Michael J. Barry ◽  
...  

2005 ◽  
Vol 12 (4_suppl) ◽  
pp. 116-117 ◽  
Author(s):  
Sunil Kripalani ◽  
Jyoti Sharma ◽  
Elizabeth Justice ◽  
Jeb Justice ◽  
Cynthia Spiker ◽  
...  

2019 ◽  
Vol 102 (8) ◽  
pp. 1483-1489 ◽  
Author(s):  
Tessa Dierks ◽  
Eveline A.M. Heijnsdijk ◽  
Ida J. Korfage ◽  
Monique J. Roobol ◽  
Harry J. de Koning

2011 ◽  
Vol 29 (7_suppl) ◽  
pp. 188-188
Author(s):  
S. L. Chang ◽  
J. C. Presti ◽  
J. P. Richie

188 Background: The AUA and American Cancer Society both recommend a shared decision-making process between clinicians and patients for prostate cancer screening with PSA testing. Data are limited data regarding patient preferences for PSA evaluation in the United States. We assessed the sociodemographic and clinical characteristics of men who proceeded with or opted out of PSA testing in a nationally representative population-based cohort. Methods: We analyzed male participants from the 2001 to 2008 cycles of the National Health and Nutrition Examination Survey (NHANES) who were 40 years old or older without a history of prostate cancer, recent prostate manipulation, or hormone therapy use (n = 6,032). All men underwent or refused PSA testing after a standardized explanation about prostate cancer screening by a physician. A multivariate logistic regression was conducted after adjusting for survey weights to identify independent sociodemographic and clinical predictors for opting out of PSA testing. Results: Overall, 5% of the study cohort refused PSA testing. The analysis revealed predictors for refusing PSA testing (Table). PSA testing preference was not influenced by a family history of prostate cancer, previous prostate cancer screening, education level, socioeconomic status, insurance status, or tobacco history. There were no significant time trends for PSA testing. Conclusions: Despite equal access to PSA testing in our study, there was unequal utilization. We found that Black men were more likely to refuse PSA testing. Our analysis also suggests that a perception of suboptimal health or uncertain future outlook may discourage men from undergoing PSA evaluation. These patient preferences for PSA evaluation should be factored into the shared decision-making process for prostate cancer screening. [Table: see text] No significant financial relationships to disclose.


2012 ◽  
Vol 30 (15_suppl) ◽  
pp. 1565-1565
Author(s):  
Thanyanan Reungwetwattana ◽  
Julian R. Molina ◽  
Jeanette Y. Ziegenfuss

1565 Background: Understanding the prevalence of cancer screening in the US and the factors associated with its accessibility is important for public health promotion. Methods: The 2004 and 2010 Behavioral Risk Factor Surveillance Systems were used to ascertain cancer screening rates among populations indicated for each test by age, gender, and the American Cancer Society recommendation for cancer screenings [fecal occult blood test (FOBT) or endoscopy for colorectal cancer (CRC) screening, digital rectal examination (DRE) or prostate specific antigen (PSA) for prostate cancer screening, clinical breast examination (CBE) or mammogram for breast cancer screening, and Papanicolaou (Pap) test for cervical cancer screening]. Results: Over this period, CRC and breast cancer screening rates significantly increased (15.9%, 13.9%) while prostate and cervical cancer screening rates significantly decreased (1.2%, 5.2%). Race/ethnicity might be an influence in CRC and cervical cancer screening accessibility. Prostate cancer screening accessibility might be influenced by education and income. The older-aged populations (70-79, >79) had high prevalence of CRC, prostate and breast cancer screenings even though there is insufficient evidence for the benefits and harms of screenings in the older-aged group. Conclusions: The disparities in age, race/ethnicity, health insurance, education, employment, and income for the accession to cancer screening of the US population have decreased since 2004. The trajectory of increasing rates of CRC and breast cancer screenings should be maintained. To reverse the trend, the causes of the decreased rate of cervical cancer screening and the high rates of screenings in older-aged populations should, however, be further explored. [Table: see text]


Sign in / Sign up

Export Citation Format

Share Document